Literature DB >> 12646513

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Johnathan M Lancaster1, Robert M Wenham, Susan Halabi, Brian Calingaert, Jeffrey R Marks, Patricia G Moorman, Rex C Bentley, Andrew Berchuck, Joellen M Schildkraut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12646513

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  8 in total

1.  Genetic variation in the progesterone receptor gene and ovarian cancer risk.

Authors:  Kathryn L Terry; Immaculata De Vivo; Linda Titus-Ernstoff; Patrick M Sluss; Daniel W Cramer
Journal:  Am J Epidemiol       Date:  2005-03-01       Impact factor: 4.897

2.  Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.

Authors:  Cunzhong Yuan; Cunfang Wang; Xiaoyan Liu; Beihua Kong
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

3.  Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.

Authors:  Eunjung Lee; Chris Hsu; Christopher A Haiman; Pedram Razavi; Pamela L Horn-Ross; David Van Den Berg; Leslie Bernstein; Loic Le Marchand; Brian E Henderson; V Wendy Setiawan; Giske Ursin
Journal:  Carcinogenesis       Date:  2010-06-13       Impact factor: 4.944

4.  Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.

Authors:  Chen Zhou; Xiangman Zou; Xiaosha Wen; Zifen Guo
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

5.  Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Authors:  Ting Liu; Lilan Chen; Xiangjun Sun; You Wang; Shu Li; Xia Yin; Xinran Wang; Chenhuan Ding; He Li; Wen Di
Journal:  Tumour Biol       Date:  2013-11-07

6.  The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdogan; Afig Berdeli; Sadik Tamsel; Fusun Saygili; Candeger Yilmaz
Journal:  Cardiovasc Diabetol       Date:  2007-10-05       Impact factor: 9.951

Review 7.  Estrogen, progesterone and epithelial ovarian cancer.

Authors:  Shuk-Mei Ho
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

8.  Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

Authors:  C L Pearce; A H Wu; S A Gayther; A E Bale; P A Beck; J Beesley; S Chanock; D W Cramer; R DiCioccio; R Edwards; Z S Fredericksen; M Garcia-Closas; E L Goode; A C Green; L C Hartmann; E Hogdall; S K Kjaer; J Lissowska; V McGuire; F Modugno; K Moysich; R B Ness; S J Ramus; H A Risch; T A Sellers; H Song; D O Stram; K L Terry; P M Webb; D C Whiteman; A S Whittemore; W Zheng; P D P Pharoah; G Chenevix-Trench; M C Pike; J Schildkraut; A Berchuck
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.